In general, overexpression of GLUT 1 and/or GLUT 3 is associated with poor prognosis in most cancer types studied, including colorectal carcinoma, breast carcinoma, lung adenocarcinoma, squamous cell carcinoma (SCC), ovarian carcinoma, and glioblastoma [38]. Here, SLC2A3 is linked to cancer.